#LCSM Chat Topic 4/2/2020: #COVID19 and #LungCancer

It seems that the world has turned upside down.  At the time I write this, there have been almost 550,00 cases of COVID-19 confirmed in the world and over 85,000 in the US.  Here in New York City there have been over 23,000 cases and 365 deaths as of March 27th (https://coronavirus.jhu.edu/map.html). The pandemic has placed enormous stress on our health care delivery system.  For lung cancer patients, it has affected healthcare providers’ ability to perform tests and radiologic procedures; provide timely diagnosis, staging, and care for early stage patients; and, in… Read More

#LCSM Chat Topic 09/19/19: World Lung (#WCLC19) Wrap-Up

Please join the #lcsm community and moderator Brendon Stiles (@BrendonStilesMD) for our next #LCSM Chat on Thursday, September 19th, 2019, at 8 pm Eastern Time (5 pm Pacific). Clinicians, researchers, patients and advocates from all over the world attended the 2019 World Conference on Lung Cancer (#WCLC19) from September 7-10 in Barcelona.  This annual event, hosted by the International Association for the Study of Lung Cancer (IASLC), is a showcase for all of the latest news and advances in lung cancer.  The meeting is somewhat unique in that it is multidisciplinary in… Read More

#LCSM Chat Topic 04/11/2019: Why research matters for lung cancer

It’s easy to understand the importance of lung cancer education and advocacy.  Of COURSE we should help patients and caregivers learn more about different types of lung cancer, biomarker testing, and treatment options.  Of course we should help them come together, to raise their voices, to make the general public understand the terrible toll lung cancer extracts from individuals and society, to combat stigma and nihilism. But what about research?  Some people suggest research isn’t as important as education or advocacy. They ask, “But what does research actually do for today’s patients?”… Read More